PMID- 12970774
OWN - NLM
STAT- MEDLINE
DCOM- 20031021
LR  - 20181130
IS  - 0887-6924 (Print)
IS  - 0887-6924 (Linking)
VI  - 17
IP  - 9
DP  - 2003 Sep
TI  - Dendritic cells: interfaces with immunobiology and medicine. A report from the 
      Keystone Symposia Meeting held in Keystone, 3-8 March 2003.
PG  - 1753-8
AB  - Dendritic cells (DCs) are the most potent antigen-presenting cells in vitro and 
      in vivo. They play a key role in the initiation of the immune response and are 
      considered promising targets for immunotherapy. The recent DC Keystone Symposia, 
      organized by Ralph M Steinman, Anne O'Garra and Jacques Banchereau, was held on 
      3-8 March 2003 in Keystone (CO, USA). This multidisciplinary meeting developed 
      various areas related to the DC biology including: (i) DC and the control of 
      immunity vs tolerance; (ii) DC maturation and manipulation for immunotherapy in 
      vivo; and (iii) antigen capture by DC in situ and interactions with microbial 
      pathogens. The aim of this report is to present some of the highlights developed 
      during the meeting and debated among the DC community.
FAU - Mohty, M
AU  - Mohty M
AD  - Laboratoire d'Immunologie des Tumeurs, Institut Paoli-Calmettes, Marseille, 
      France.
FAU - Gaugler, B
AU  - Gaugler B
LA  - eng
PT  - Congress
PT  - Research Support, Non-U.S. Gov't
PL  - England
TA  - Leukemia
JT  - Leukemia
JID - 8704895
SB  - IM
MH  - Animals
MH  - Antigen Presentation/*immunology
MH  - Dendritic Cells/*immunology
MH  - Humans
MH  - Immunity, Cellular/immunology
MH  - Immunotherapy
MH  - Neoplasms/*immunology/therapy
EDAT- 2003/09/13 05:00
MHDA- 2003/10/22 05:00
CRDT- 2003/09/13 05:00
PHST- 2003/09/13 05:00 [pubmed]
PHST- 2003/10/22 05:00 [medline]
PHST- 2003/09/13 05:00 [entrez]
AID - 2403049 [pii]
AID - 10.1038/sj.leu.2403049 [doi]
PST - ppublish
SO  - Leukemia. 2003 Sep;17(9):1753-8. doi: 10.1038/sj.leu.2403049.